FDA approves BioCryst's oral pellet version of swelling disorder drug for children – Reuters

1. FDA approves BioCryst’s oral pellet version of swelling disorder drug for children  Reuters
2. Why Are Retail Traders Going Gaga Over BioCryst Pharma Stock Today?  Stocktwits
3. BioCryst’s Orladeyo wins expanded FDA approval  The Pharma Letter
4. FDA approves berotralstat for patients aged 2 to  Contemporary Pediatrics
5. FDA Gives Green Light to BioCryst’s (BCRX) ORLADEYO for Pediatri  GuruFocus

Continue Reading